{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T22:41:32Z","timestamp":1785796892223,"version":"3.56.0"},"reference-count":50,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,11,18]],"date-time":"2022-11-18T00:00:00Z","timestamp":1668729600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000196","name":"Canada Foundation for Innovation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000196","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001804","name":"Canada Research Chairs","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001804","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007919","name":"University of Massachusetts","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007919","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","award":["FND167283"],"award-info":[{"award-number":["FND167283"]}],"id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal for Parasitology: Drugs and Drug Resistance"],"published-print":{"date-parts":[[2023,4]]},"DOI":"10.1016\/j.ijpddr.2022.11.004","type":"journal-article","created":{"date-parts":[[2022,11,25]],"date-time":"2022-11-25T16:00:15Z","timestamp":1669392015000},"page":"13-20","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":18,"special_numbering":"C","title":["Thiophene derivatives activity against the protozoan parasite Leishmania infantum"],"prefix":"10.1016","volume":"21","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7600-1478","authenticated-orcid":false,"given":"Sophia","family":"Bigot","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philippe","family":"Leprohon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3088-4540","authenticated-orcid":false,"given":"Abimael","family":"Vasquez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rohit","family":"Bhadoria","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3324-4362","authenticated-orcid":false,"given":"Rachid","family":"Skouta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc","family":"Ouellette","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijpddr.2022.11.004_bib1","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0035671","article-title":"Leishmaniasis worldwide and global estimates of its incidence","volume":"7","author":"Alvar","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.ijpddr.2022.11.004_bib2","volume":"vol. 7","author":"Andrade","year":"2014"},{"key":"10.1016\/j.ijpddr.2022.11.004_bib3","doi-asserted-by":"crossref","first-page":"3802","DOI":"10.1128\/AAC.02529-15","article-title":"Novel heteroaryl selenocyanates and diselenides as potent antileishmanial agents","volume":"60","author":"Baquedano","year":"2016","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ijpddr.2022.11.004_bib4","doi-asserted-by":"crossref","first-page":"5627","DOI":"10.1038\/s41467-019-13344-6","article-title":"Coupling chemical mutagenesis to next generation sequencing for the identification of drug resistance mutations in Leishmania","volume":"10","author":"Bhattacharya","year":"2019","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ijpddr.2022.11.004_bib5","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0009377","article-title":"Combined gene deletion of dihydrofolate reductase-thymidylate synthase and pteridine reductase in Leishmania infantum","volume":"15","author":"Bhattacharya","year":"2021","journal-title":"PLoS Neglected Trop. Dis."},{"key":"10.1016\/j.ijpddr.2022.11.004_bib6","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2019.111676","article-title":"Discovery of a benzothiophene-flavonol halting miltefosine and antimonial drug resistance in Leishmania parasites through the application of medicinal chemistry, screening and genomics","volume":"183","author":"Borsari","year":"2019","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ijpddr.2022.11.004_bib7","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0081899","article-title":"Proteomic and genomic analyses of antimony resistant Leishmania infantum mutant","volume":"8","author":"Brotherton","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.ijpddr.2022.11.004_bib8","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.ijpddr.2014.05.002","article-title":"Quantitative proteomic analysis of amphotericin B resistance in Leishmania infantum","volume":"4","author":"Brotherton","year":"2014","journal-title":"Int J Parasitol Drugs Drug Resist"},{"key":"10.1016\/j.ijpddr.2022.11.004_bib9","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0005781","article-title":"Systematic review of clinical trials assessing the therapeutic efficacy of visceral leishmaniasis treatments: a first step to assess the feasibility of establishing an individual patient data sharing platform","volume":"11","author":"Bush","year":"2017","journal-title":"PLoS Neglected Trop. Dis."},{"key":"10.1016\/j.ijpddr.2022.11.004_bib10","doi-asserted-by":"crossref","first-page":"7622","DOI":"10.1128\/AAC.04457-14","article-title":"Comparison of a high-throughput high-content intracellular leishmania donovani assay with an axenic amastigote assay (vol 57, pg 2913, 2013","volume":"58","author":"De Rycker","year":"2014","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ijpddr.2022.11.004_bib11","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1038\/ng.806","article-title":"A framework for variation discovery and genotyping using next-generation DNA sequencing data","volume":"43","author":"DePristo","year":"2011","journal-title":"Nat. Genet."},{"key":"10.1016\/j.ijpddr.2022.11.004_bib12","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.ijpddr.2018.03.004","article-title":"High-throughput Cos-Seq screen with intracellular Leishmania infantum for the discovery of novel drug-resistance mechanisms","volume":"8","author":"Fernandez-Prada","year":"2018","journal-title":"Int J Parasitol Drugs Drug Resist"},{"key":"10.1016\/j.ijpddr.2022.11.004_bib13","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/S0076-6879(02)47024-3","article-title":"Tryparedoxin and tryparedoxin peroxidase","volume":"347","author":"Flohe","year":"2002","journal-title":"Protein Sensors and Reactive Oxygen Species, Pt a, Selenoproteins and Thioredoxin"},{"key":"10.1016\/j.ijpddr.2022.11.004_bib14","doi-asserted-by":"crossref","first-page":"E3012","DOI":"10.1073\/pnas.1520693113","article-title":"Cos-Seq for high-throughput identification of drug target and resistance mechanisms in the protozoan parasite Leishmania","volume":"113","author":"Gazanion","year":"2016","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.ijpddr.2022.11.004_bib15","doi-asserted-by":"crossref","first-page":"48275","DOI":"10.1074\/jbc.M310223200","article-title":"ABCG5 and ABCG8 are obligate heterodimers for protein trafficking and biliary cholesterol excretion","volume":"278","author":"Graf","year":"2003","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ijpddr.2022.11.004_bib16","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1016\/j.ejmech.2016.08.048","article-title":"Synthesis and evaluation against Leishmania amazonensis of novel pyrazolo[3,4-d]pyridazinone-N-acylhydrazone-(bi)thiophene hybrids","volume":"124","author":"Jacomini","year":"2016","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ijpddr.2022.11.004_bib17","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1016\/j.ejmech.2017.07.038","article-title":"An overview of benzo b thiophene-based medicinal chemistry","volume":"138","author":"Keri","year":"2017","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ijpddr.2022.11.004_bib18","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1038\/clpt.2009.79","article-title":"ABCG2 polymorphism markedly affects the pharmacokinetics of atorvastatin and rosuvastatin","volume":"86","author":"Keskitalo","year":"2009","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.ijpddr.2022.11.004_bib19","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1007\/s11095-005-2487-9","article-title":"Lack of improvement of oral absorption of ME3277 by prodrug formation is ascribed to the intestinal efflux mediated by breast cancer resistant protein (BCRP\/ABCG2)","volume":"22","author":"Kondo","year":"2005","journal-title":"Pharmaceut. Res."},{"key":"10.1016\/j.ijpddr.2022.11.004_bib20","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.ijpddr.2014.09.005","article-title":"Drug resistance analysis by next generation sequencing in Leishmania","volume":"5","author":"Leprohon","year":"2015","journal-title":"Int J Parasitol Drugs Drug Resist"},{"key":"10.1016\/j.ijpddr.2022.11.004_bib21","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1128\/EC.00152-06","article-title":"Modulation of Leishmania ABC protein gene expression through life stages and among drug-resistant parasites","volume":"5","author":"Leprohon","year":"2006","journal-title":"Eukaryot. Cell"},{"key":"10.1016\/j.ijpddr.2022.11.004_bib22","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/S0166-6851(98)00122-4","article-title":"Identification and characterisation of a functional peroxidoxin from Leishmania major","volume":"96","author":"Levick","year":"1998","journal-title":"Mol. Biochem. Parasitol."},{"key":"10.1016\/j.ijpddr.2022.11.004_bib23","doi-asserted-by":"crossref","first-page":"1754","DOI":"10.1093\/bioinformatics\/btp324","article-title":"Fast and accurate short read alignment with Burrows-Wheeler transform","volume":"25","author":"Li","year":"2009","journal-title":"Bioinformatics"},{"key":"10.1016\/j.ijpddr.2022.11.004_bib24","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1101\/gr.107524.110","article-title":"The Genome Analysis Toolkit: a MapReduce framework for analyzing next-generation DNA sequencing data","volume":"20","author":"McKenna","year":"2010","journal-title":"Genome Res."},{"key":"10.1016\/j.ijpddr.2022.11.004_bib25","doi-asserted-by":"crossref","first-page":"e201","DOI":"10.1038\/cddis.2011.83","article-title":"Tolerance to drug-induced cell death favours the acquisition of multidrug resistance in Leishmania","volume":"2","author":"Moreira","year":"2011","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.ijpddr.2022.11.004_bib26","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1515\/znc-2016-0129","article-title":"Synthesis and biological evaluation of newer 1,3,4-oxadiazoles incorporated with benzothiazepine and benzodiazepine moieties","volume":"72","author":"Navin","year":"2017","journal-title":"Z. Naturforsch. C Biosci."},{"key":"10.1016\/j.ijpddr.2022.11.004_bib27","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0006157","article-title":"Discovery of novel, orally bioavailable, antileishmanial compounds using phenotypic screening","volume":"11","author":"Ortiz","year":"2017","journal-title":"PLoS Neglected Trop. Dis."},{"key":"10.1016\/j.ijpddr.2022.11.004_bib28","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.molbiopara.2008.08.007","article-title":"Functional analysis and complex gene rearrangements of the folate\/biopterin transporter (FBT) gene family in the protozoan parasite Leishmania","volume":"162","author":"Ouameur","year":"2008","journal-title":"Mol. Biochem. Parasitol."},{"key":"10.1016\/j.ijpddr.2022.11.004_bib29","doi-asserted-by":"crossref","DOI":"10.15252\/embr.202050249","article-title":"Exploiting antimicrobial resistance Better knowledge of resistance mechanisms can inform the search for and development of new antibiotics","volume":"21","author":"Ouellette","year":"2020","journal-title":"EMBO Rep."},{"key":"10.1016\/j.ijpddr.2022.11.004_bib30","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1002\/j.1460-2075.1990.tb08206.x","article-title":"The amplified H circle of methotrexate-resistant leishmania tarentolae contains a novel P-glycoprotein gene","volume":"9","author":"Ouellette","year":"1990","journal-title":"EMBO J."},{"key":"10.1016\/j.ijpddr.2022.11.004_bib31","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1021\/acsmedchemlett.1c00193","article-title":"Monocyclic nitro-heteroaryl nitrones with dual mechanism of activation: synthesis and antileishmanial activity","volume":"12","author":"Pacheco","year":"2021","journal-title":"ACS Med. Chem. Lett."},{"key":"10.1016\/j.ijpddr.2022.11.004_bib32","doi-asserted-by":"crossref","first-page":"3601","DOI":"10.1002\/j.1460-2075.1992.tb05444.x","article-title":"A novel antifolate resistance gene on the amplified H circle of Leishmania","volume":"11","author":"Papadopoulou","year":"1992","journal-title":"EMBO J."},{"key":"10.1016\/j.ijpddr.2022.11.004_bib33","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/0166-6851(94)90113-9","article-title":"Autonomous replication of bacterial-dna plasmid oligomers in leishmania","volume":"65","author":"Papadopoulou","year":"1994","journal-title":"Mol. Biochem. Parasitol."},{"key":"10.1016\/j.ijpddr.2022.11.004_bib34","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1002\/cmdc.200900098","article-title":"Synthesis and evaluation of 1-(1-(benzo b thiophen-2-yl)cyclohexyl)piperidine (BTCP) analogues as inhibitors of trypanothione reductase","volume":"4","author":"Patterson","year":"2009","journal-title":"ChemMedChem"},{"key":"10.1016\/j.ijpddr.2022.11.004_bib35","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1038\/ng2053","article-title":"Comparative genomic analysis of three Leishmania species that cause diverse human disease","volume":"39","author":"Peacock","year":"2007","journal-title":"Nat. Genet."},{"key":"10.1016\/j.ijpddr.2022.11.004_bib36","doi-asserted-by":"crossref","first-page":"8771","DOI":"10.1038\/srep08771","article-title":"New compound sets identified from high throughput phenotypic screening against three kinetoplastid parasites: an open resource","volume":"5","author":"Pena","year":"2015","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ijpddr.2022.11.004_bib37","doi-asserted-by":"crossref","first-page":"3489","DOI":"10.1128\/AAC.02813-15","article-title":"The LABCG2 transporter from the Protozoan parasite leishmania is involved in antimony resistance","volume":"60","author":"Perea","year":"2016","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ijpddr.2022.11.004_bib38","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0006052","article-title":"Drug resistance and treatment failure in leishmaniasis: a 21st century challenge","volume":"11","author":"Ponte-Sucre","year":"2017","journal-title":"PLoS Neglected Trop. Dis."},{"key":"10.1016\/j.ijpddr.2022.11.004_bib39","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1007\/978-1-4939-9210-2_7","article-title":"Cos-seq: a high-throughput gain-of-function screen for drug resistance studies in leishmania","author":"Potvin","year":"2019","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.ijpddr.2022.11.004_bib40","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ejmech.2015.10.011","article-title":"2-Amino-thiophene derivatives present antileishmanial activity mediated by apoptosis and immunomodulation in vitro","volume":"106","author":"Rodrigues","year":"2015","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ijpddr.2022.11.004_bib41","doi-asserted-by":"crossref","DOI":"10.3390\/molecules23071626","article-title":"Development of thiophene compounds as potent chemotherapies for the treatment of cutaneous leishmaniasis caused by","volume":"23","author":"Rodriguez","year":"2018","journal-title":"Molecules"},{"key":"10.1016\/j.ijpddr.2022.11.004_bib42","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/S0166-6851(00)00270-X","article-title":"Episomal and stable expression of the luciferase reporter gene for quantifying Leishmania spp. infections in macrophages and in animal models","volume":"110","author":"Roy","year":"2000","journal-title":"Mol. Biochem. Parasitol."},{"key":"10.1016\/j.ijpddr.2022.11.004_bib43","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1111\/j.2042-7158.1991.tb05452.x","article-title":"Evaluation of in-vitro leishmanicidal activity of hydrazones of thiophene carboxaldehydes against promastigotes of Leishmania infantum and Leishmania tropica","volume":"43","author":"Savornin","year":"1991","journal-title":"J. Pharm. Pharmacol."},{"key":"10.1016\/j.ijpddr.2022.11.004_bib44","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.1128\/AAC.45.4.1168-1173.2001","article-title":"DNA transformation of Leishmania infantum axenic amastigotes and their use in drug screening","volume":"45","author":"Sereno","year":"2001","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ijpddr.2022.11.004_bib45","volume":"vol. 118","author":"Sun","year":"2021"},{"key":"10.1016\/j.ijpddr.2022.11.004_bib46","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.ijpddr.2019.02.002","article-title":"Novel benzoxaborole, nitroimidazole and aminopyrazoles with activity against experimental cutaneous leishmaniasis","volume":"11","author":"Van Bocxlaer","year":"2019","journal-title":"International Journal for Parasitology-Drugs and Drug Resistance"},{"key":"10.1016\/j.ijpddr.2022.11.004_bib47","doi-asserted-by":"crossref","DOI":"10.3390\/microorganisms9071408","article-title":"Identification of resistance determinants for a promising antileishmanial oxaborole series","volume":"9","author":"Van den Kerkhof","year":"2021","journal-title":"Microorganisms"},{"key":"10.1016\/j.ijpddr.2022.11.004_bib48","doi-asserted-by":"crossref","first-page":"2368","DOI":"10.1021\/acs.molpharmaceut.7b00277","article-title":"Overexpression of ATP-binding cassette subfamily G member 2 confers resistance to phosphatidylinositol 3-kinase inhibitor PF-4989216 in cancer cells","volume":"14","author":"Wu","year":"2017","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.ijpddr.2022.11.004_bib49","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.molbiopara.2010.05.015","article-title":"Elevated levels of tryparedoxin peroxidase in antimony unresponsive Leishmania donovani field isolates","volume":"173","author":"Wyllie","year":"2010","journal-title":"Mol. Biochem. Parasitol."},{"key":"10.1016\/j.ijpddr.2022.11.004_bib50","doi-asserted-by":"crossref","DOI":"10.1128\/mBio.00861-15","article-title":"CRISPR-Cas9-Mediated genome editing in leishmania donovani","volume":"6","author":"Zhang","year":"2015","journal-title":"mBio"}],"container-title":["International Journal for Parasitology: Drugs and Drug Resistance"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211320722000318?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211320722000318?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T14:51:24Z","timestamp":1761922284000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2211320722000318"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4]]},"references-count":50,"alternative-id":["S2211320722000318"],"URL":"https:\/\/doi.org\/10.1016\/j.ijpddr.2022.11.004","relation":{},"ISSN":["2211-3207"],"issn-type":[{"value":"2211-3207","type":"print"}],"subject":[],"published":{"date-parts":[[2023,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Thiophene derivatives activity against the protozoan parasite Leishmania infantum","name":"articletitle","label":"Article Title"},{"value":"International Journal for Parasitology: Drugs and Drug Resistance","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijpddr.2022.11.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Authors. Published by Elsevier Ltd on behalf of Australian Society for Parasitology.","name":"copyright","label":"Copyright"}]}}